Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 26(20)2021 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-34684678

RESUMEN

BACKGROUND: The blockade of the progression or onset of pathological events is essential for the homeostasis of an organism. Some common pathological mechanisms involving a wide range of diseases are the uncontrolled inflammatory reactions that promote fibrosis, oxidative reactions, and other alterations. Natural plant compounds (NPCs) are bioactive elements obtained from natural sources that can regulate physiological processes. Inflammation is recognized as an important factor in the development and evolution of chronic renal damage. Consequently, any compound able to modulate inflammation or inflammation-related processes can be thought of as a renal protective agent and/or a potential treatment tool for controlling renal damage. The objective of this research was to review the beneficial effects of bioactive natural compounds on kidney damage to reveal their efficacy as demonstrated in clinical studies. METHODS: This systematic review is based on relevant studies focused on the impact of NPCs with therapeutic potential for kidney disease treatment in humans. RESULTS: Clinical studies have evaluated NPCs as a different way to treat or prevent renal damage and appear to show some benefits in improving OS, inflammation, and antioxidant capacity, therefore making them promising therapeutic tools to reduce or prevent the onset and progression of KD pathogenesis. CONCLUSIONS: This review shows the promising clinical properties of NPC in KD therapy. However, more robust clinical trials are needed to establish their safety and therapeutic effects in the area of renal damage.


Asunto(s)
Enfermedades Renales/tratamiento farmacológico , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Antioxidantes/farmacología , Berberina/farmacología , Beta vulgaris , Betalaínas/farmacología , Productos Biológicos/farmacología , Catequina/farmacología , Curcumina/farmacología , Disulfuros/farmacología , Flavonoides/farmacología , Humanos , Isotiocianatos/farmacología , Riñón/efectos de los fármacos , Riñón/patología , Granada (Fruta) , Resveratrol/farmacología , Ácidos Sulfínicos/farmacología , Sulfóxidos/farmacología , Xantófilas/farmacología
2.
Antibiotics (Basel) ; 8(4)2019 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-31652990

RESUMEN

Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, and more than half of them become infected. Therefore, it is essential to manage infection and ulcer recovery to prevent negatives outcomes. The available information plays a significant role in keeping both physicians and patients aware of the emerging therapies against DFUs. The purpose of this review is to compile the currently available approaches in the managing and treatment of DFUs, including molecular and regenerative medicine, antimicrobial and energy-based therapies, and the use of plant extracts, antimicrobial peptides, growth factors, ozone, devices, and nano-medicine, to offer an overview of the assessment of this condition.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA